Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
S G Ralph a Department of Genitourinary Medicine,
General Infirmary at Leeds, Leeds LS1 3EX, b Reproductive Medicine Unit, General Infirmary at
Leeds
Correspondence to: J D Wilson
jdwilson{at}dunham.freeuk.com
Objectives:
To assess whether bacterial vaginosis
affects the rates of conception and miscarriage in the first trimester.
Design:
Cohort study.
Setting:
Assisted conception unit of a teaching
hospital in Leeds.
Participants:
867 consecutive women undergoing in
vitro fertilisation.
Interventions:
Screening for bacterial vaginosis with
a Gram stained vaginal smear before egg collection.
Main outcome measures:
The presence of bacterial
vaginosis or normal vaginal flora, and the rate of conception and
miscarriage in the first trimester.
Results:
190 of 771 (24.6%) women had bacterial
vaginosis. No difference in conception rate was found between those
women with bacterial vaginosis and those with normal vaginal flora: 61 women (32.1%) and 146 of 493 women (29.6%) respectively (relative risk 1.08, 95% confidence interval 0.85 to 1.39; odds ratio 1.12, 0.77 to 1.64). However, 22 women (31.6%) with bacterial vaginosis who
conceived had a significantly increased risk of miscarriage in the
first trimester compared with 27 women (18.5%) with normal vaginal
flora (crude relative risk 1.95, 1.11 to 3.42; crude odds ratio 2.49, 1.21 to 5.12). This increased risk remained significant after
adjustment for factors known to increase the rate of miscarriage: increasing maternal age, smoking, history of three or more
miscarriages, no previous live birth, and polycystic ovaries (adjusted
relative risk 2.03, 1.09 to 3.78; adjusted odds ratio 2.67, 1.26 to
5.63).
Conclusions:
Bacterial vaginosis does not
affect conception but is associated with an increased risk of
miscarriage in the first trimester in women undergoing in vitro
fertilisation, independent of other risk factors.
Key messages
Read all Rapid Responses
What can you learn from this BMJ paper? Read Leanne Tite's Paper+